Patents by Inventor Stephen Boyd

Stephen Boyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hard-surface disinfection system
    Patent number: 9592312
    Abstract: UV hard-surface disinfection system that is able to disinfect the hard surfaces in a room, while minimizing missed areas due to shadows by providing multiple UV light towers that can be placed in several areas of a room such that shadowed areas are eliminated and that can be transported by a cart that is low to the ground such that the towers may be loaded and unloaded easily by a single operator. The system is able to be controlled remotely, such that during activation of the system, no operator is present, and to automatically cut power to all towers in the event that a person enters the room.
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: March 14, 2017
    Assignee: Surfacide, LLC
    Inventors: Waldemar John Lyslo, Mark Howard Schwartz, Stephen Boyd Pettis
  • ANTERIOR SEGMENT DRUG DELIVERY
    Publication number: 20170056242
    Abstract: A therapeutic system comprises an ocular insert placed on a region outside an optical zone of an eye. The ocular insert comprises two structures: a first skeletal structure and a second cushioning structure. The first structure functions as a skeletal frame which maintains positioning of the implant along the anterior portion of the eye and provides support to the second, cushioning structure. This first structure maintains the attachment of the therapeutic system to the anterior portion of the eye for at least thirty days. In some embodiments the first structure remains a constant size and shape, e.g. a ring shape, a ring with haptics, or a curvilinear ring that is confined to and restrainingly engages the inferior and superior conjunctival fornices so as to retain the implant within the tear fluid and/or against the tissues of the eye.
    Type: Application
    Filed: August 5, 2016
    Publication date: March 2, 2017
    Inventors: Yair Alster, Eugene de Juan, JR., Cary J. Reich, Stephen Boyd, David Sierra, Jose D. Alejandro, K. Angela Macfarlane, Douglas Sutton
  • EMBEDDED DOWEL INSERTS
    Publication number: 20170051500
    Abstract: A dowel supporting device that includes a substantially hollow tube having a top end and a bottom end. An opening may be formed at the top end and a base may be formed at the bottom end. The base of the dowel supporting device may be fastened to a concrete deck. Concrete may be poured into the concrete deck. When dowels are ready to be used, the dowels may be inserted and secured to the dowel supporting device.
    Type: Application
    Filed: October 14, 2016
    Publication date: February 23, 2017
    Inventors: Stephen Boyd, Joseph Accetta
  • METHODS AND DEVICES TO TREAT DISEASED OR INJURED MUSCULSKELETAL TISSUE
    Publication number: 20170020505
    Abstract: A knotless suture anchoring system includes an outer anchor having a central channel and a distal tip adapted to penetrate tissue. An inner anchor is positionable in the central channel of the outer anchor and a locking feature on one or both of the inner and outer anchors retains the inner anchor within the central channel. A continuous length of suture is coupled with the inner and outer suture anchors and has a free end. At least one of the inner and the outer anchors also has a cinching mechanism that allows the suture to be tensioned by passage of the suture through the cinching mechanism in a first direction while movement of the suture through the cinching mechanism in a second direction opposite the first direction is constrained.
    Type: Application
    Filed: June 23, 2016
    Publication date: January 26, 2017
    Inventors: Darin C. Gittings, Mark Deem, Michael Hendricksen, Vivek Shenoy, Hanson S. Gifford, III, Stephen Boyd
  • Scleral and conjuctival implants for drug therapy
    Patent number: 9549852
    Abstract: An implant for insertion through a punctum and into a canalicular lumen of a patient. The implant includes a matrix of material, a therapeutic agent dispersed in the matrix of material, a sheath disposed over a portion of the matrix of material and configured to inhibit the therapeutic agent from being released from the matrix of material into the canalicular lumen and to allow the therapeutic agent to be released from a surface of the matrix of material to a tear film, and a retention structure configured to retain the implant within the canalicular lumen.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: January 24, 2017
    Assignee: Mati Therapeutics Inc.
    Inventors: Eugene de Juan, Jr., Stephen Boyd, Cary Reich, Alan Rapacki, Hanson S Gifford, Mark Deem
  • Aortic Valve Repair
    Publication number: 20170014183
    Abstract: The present invention provides devices and methods for decalcifying an aortic valve. The methods and devices of the present invention break up or obliterate calcific deposits in and around the aortic valve through application or removal of heat energy from the calcific deposits.
    Type: Application
    Filed: July 18, 2016
    Publication date: January 19, 2017
    Inventors: Hanson Gifford, III, Mark Deem, Stephen Boyd
  • Embedded dowel inserts
    Patent number: 9469994
    Abstract: A dowel supporting device that includes a substantially hollow tube having a top end and a bottom end. An opening may be formed at the top end and a base may be formed at the bottom end. The base of the dowel supporting device may be fastened to a concrete deck. Concrete may be poured into the concrete deck. When dowels are ready to be used, the dowels may be inserted and secured to the dowel supporting device.
    Type: Grant
    Filed: August 12, 2013
    Date of Patent: October 18, 2016
    Inventors: Stephen Boyd, Joseph Accetta
  • Methods and devices to treat diseased or injured musculoskeletal tissue
    Patent number: 9463010
    Abstract: A knotless suture anchoring system includes an outer anchor having a central channel and a distal tip adapted to penetrate tissue. An inner anchor is positionable in the central channel of the outer anchor and a locking feature on one or both of the inner and outer anchors retains the inner anchor within the central channel. A continuous length of suture is coupled with the inner and outer suture anchors and has a free end. At least one of the inner and the outer anchors also has a cinching mechanism that allows the suture to be tensioned by passage of the suture through the cinching mechanism in a first direction while movement of the suture through the cinching mechanism in a second direction opposite the first direction is constrained.
    Type: Grant
    Filed: January 24, 2013
    Date of Patent: October 11, 2016
    Assignee: The Foundry, LLC
    Inventors: Darin C. Gittings, Mark Deem, Michael Hendricksen, Vivek Shenoy, Hanson S. Gifford, III, Stephen Boyd
  • Anterior segment drug delivery
    Patent number: 9421126
    Abstract: A therapeutic system comprises an ocular insert placed on a region outside an optical zone of an eye. The ocular insert comprises two structures: a first skeletal structure and a second cushioning structure. The first structure functions as a skeletal frame which maintains positioning of the implant along the anterior portion of the eye and provides support to the second, cushioning structure. This first structure maintains the attachment of the therapeutic system to the anterior portion of the eye for at least thirty days. In some embodiments the first structure remains a constant size and shape, e.g. a ring shape, a ring with haptics, or a curvilinear ring that is confined to and restrainingly engages the inferior and superior conjunctival fornices so as to retain the implant within the tear fluid and/or against the tissues of the eye.
    Type: Grant
    Filed: June 1, 2011
    Date of Patent: August 23, 2016
    Assignee: ForSight Vision5, Inc.
    Inventors: Yair Alster, Eugene de Juan, Jr., Cary J. Reich, Stephen Boyd, David Sierra, Jose D. Alejandro, K. Angela Macfarlane, Douglas Sutton
  • Aortic valve repair
    Patent number: 9414852
    Abstract: The present invention provides devices and methods for decalcifying an aortic valve. The methods and devices of the present invention break up or obliterate calcific deposits in and around the aortic valve through application or removal of heat energy from the calcific deposits.
    Type: Grant
    Filed: December 3, 2012
    Date of Patent: August 16, 2016
    Assignee: Twelve, Inc.
    Inventors: Hanson Gifford, III, Mark Deem, Stephen Boyd
  • Glaucoma treatment device
    Patent number: 9398977
    Abstract: Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: July 26, 2016
    Assignee: Transcend Medical, Inc.
    Inventors: Eugene de Juan, Jr., Stephen Boyd, Mark E. Deem, Hanson S. Gifford, III, Dan Rosenman
  • Hard-Surface Disinfection System
    Publication number: 20160151524
    Abstract: UV hard-surface disinfection system that is able to disinfect the hard surfaces in a room, while minimizing missed areas due to shadows by providing multiple UV light towers that can be placed in several areas of a room such that shadowed areas are eliminated and that can be transported by a cart that is low to the ground such that the towers may be loaded and unloaded easily by a single operator. The system is able to be controlled remotely, such that during activation of the system, no operator is present, and to automatically cut power to all towers in the event that a person enters the room.
    Type: Application
    Filed: February 8, 2016
    Publication date: June 2, 2016
    Applicant: Surfacide, LLC
    Inventors: Waldemar John Lyslo, Mark Howard Schwartz, Stephen Boyd Pettis
  • Friction Reducing Additive
    Publication number: 20160090544
    Abstract: An automotive engine oil and/or fuel comprising a base stock and an organic polymeric friction reducing additive is claimed. A method of reducing friction in an automotive engine oil and/or fuel by the addition of the organic polymeric friction reducing additive to the base stock is also claimed.
    Type: Application
    Filed: December 2, 2015
    Publication date: March 31, 2016
    Inventors: Lee Thompson, Steven James Randles, Stephen Boyde, John Gamwell, Nicola Readman
  • Hard-surface disinfection system
    Patent number: 9272059
    Abstract: UV hard-surface disinfection system that is able to disinfect the hard surfaces in a room, while minimizing missed areas due to shadows by providing multiple UV light towers that can be placed in several areas of a room such that shadowed areas are eliminated and that can be transported by a cart that is low to the ground such that the towers may be loaded and unloaded easily by a single operator. The system is able to be controlled remotely, such that during activation of the system, no operator is present, and to automatically cut power to all towers in the event that a person enters the room.
    Type: Grant
    Filed: November 13, 2014
    Date of Patent: March 1, 2016
    Assignee: Surfacide, LLC
    Inventors: Waldemar John Lyslo, Mark Howard Schwartz, Stephen Boyd Pettis
  • NASOLACRIMAL DRAINAGE SYSTEM IMPLANTS FOR DRUG THERAPY
    Publication number: 20160008171
    Abstract: An implant for insertion through a punctum and into a canalicular lumen of a patient. The implant includes a matrix of material, a therapeutic agent dispersed in the matrix of material, a sheath disposed over a portion of the matrix of material and configured to inhibit the therapeutic agent from being released from the matrix of material into the canalicular lumen and to allow the therapeutic agent to be released from a surface of the matrix of material to a tear film, and a retention structure configured to retain the implant within the canalicular lumen.
    Type: Application
    Filed: September 18, 2015
    Publication date: January 14, 2016
    Inventors: Eugene de Juan, JR., Stephen Boyd, Cary Reich, Alan Rapacki, Hanson S. Gifford, Mark Deem
  • Friction reducing additive
    Patent number: 9228152
    Abstract: An automotive engine oil and/or fuel comprising a base stock and an organic polymeric friction reducing additive is claimed. A method of reducing friction in an automotive engine oil and/or fuel by the addition of the organic polymeric friction reducing additive to the base stock is also claimed.
    Type: Grant
    Filed: March 3, 2011
    Date of Patent: January 5, 2016
    Assignee: CRODA INTERNATIONAL PLC
    Inventors: Lee Thompson, Steven James Randles, Stephen Boyde, John Gamwell, Nicola Readman
  • LACRIMAL IMPLANT DETECTION
    Publication number: 20150374541
    Abstract: This document discusses, among other things, an apparatus comprising a lacrimal implant insertable at least partially into a lacrimal punctum. The lacrimal implant comprises an implant core, and an implant body. The implant body includes a cavity sized and shaped to receive the implant core. At least one of the implant core and the implant cavity includes a detection device configured to allow automatic detection of the lacrimal implant with a separate detector device.
    Type: Application
    Filed: April 20, 2015
    Publication date: December 31, 2015
    Inventors: Eugene de Juan, JR., Stephen Boyd, Cary J. Reich, Christopher V. Cardenas, Tommy Jewell, Lorrie Ma, Tuan Nguyen
  • Nasolacrimal drainage system implants for drug therapy
    Patent number: 9168222
    Abstract: An implant for insertion through a punctum and into a canalicular lumen of a patient. The implant includes a matrix of material, a therapeutic agent dispersed in the matrix of material, a sheath disposed over a portion of the matrix of material and configured to inhibit the therapeutic agent from being released from the matrix of material into the canalicular lumen and to allow the therapeutic agent to be released from a surface of the matrix of material to a tear film, and a retention structure configured to retain the implant within the canalicular lumen.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: October 27, 2015
    Assignee: Mati Therapeutics Inc.
    Inventors: Eugene De Juan, Jr., Stephen Boyd, Cary Reich, Alan Rapacki, Hanson S Gifford, Mark Deem
  • Method of correcting vision using corneal onlays
    Patent number: 9125735
    Abstract: A corneal onlay is configured to adhere to the cornea so as to inhibit epithelial growth under the onlay. Structures can be provided on the onlay to adhere the onlay to the eye. At least one of an epithelial layer or the water inhibiting layer can be provided on or over the onlay, for example a natural epithelial layer or water inhibiting layer that inhibits, for example minimizes, water penetration into the onlay, so as to adhere the onlay to the eye with pumping of the endothelium. The water inhibiting layer may comprise a therapeutic covering positioned over the onlay to inhibit swelling of the cornea. The posterior surface of the onlay may be shaped so as to fit the anterior exposed surface of the cornea.
    Type: Grant
    Filed: October 4, 2010
    Date of Patent: September 8, 2015
    Assignee: Forsight Labs, LLC
    Inventors: Eugene de Juan, Jr., Cary J. Reich, Stephen Boyd, David Sierra, Jose D. Alejandro
  • Glaucoma Treatment Device
    Publication number: 20150238360
    Abstract: Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.
    Type: Application
    Filed: May 7, 2015
    Publication date: August 27, 2015
    Inventors: Eugene de Juan, JR., Stephen Boyd, Mark E. Deem, Hanson S. Gifford, III, Dan Rosenman